{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:00:29Z","timestamp":1778076029092,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10067-018-4272-2","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T06:31:13Z","timestamp":1535178673000},"page":"425-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases"],"prefix":"10.1007","volume":"38","author":[{"given":"Marion","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Forien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Dieud\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"key":"4272_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/rheumatology\/kep081","volume":"48","author":"P Richette","year":"2009","unstructured":"Richette P, Bardin T, Doherty M (2009) An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) 48:711\u2013715","journal-title":"Rheumatology (Oxford)"},{"key":"4272_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/ard.62.6.513","volume":"62","author":"RL Neame","year":"2003","unstructured":"Neame RL, Carr AJ, Muir K, Doherty M (2003) UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 62:513\u2013518","journal-title":"Ann Rheum Dis"},{"key":"4272_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.2010.139105","volume":"70","author":"W Zhang","year":"2011","unstructured":"Zhang W, Doherty M, Bardin T, Barskova V, Guerne P-A, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Pascual E (2011) European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 70:563\u2013570","journal-title":"Ann Rheum Dis"},{"key":"4272_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29\u201342","journal-title":"Ann Rheum Dis"},{"key":"4272_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","volume":"38","author":"RA Terkeltaub","year":"2009","unstructured":"Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411\u2013419","journal-title":"Semin Arthritis Rheum"},{"key":"4272_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241","journal-title":"Nature"},{"key":"4272_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejim.2010.03.005","volume":"21","author":"I Mitroulis","year":"2010","unstructured":"Mitroulis I, Skendros P, Ritis K (2010) Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. Eur J Intern Med 21:157\u2013163","journal-title":"Eur J Intern Med"},{"key":"4272_CR8","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/ar4303","volume":"15","author":"S Ottaviani","year":"2013","unstructured":"Ottaviani S, Molt\u00f3 A, Ea H-K, Neveu S, Gill G, Brunier L, Palazzo E, Meyer O, Richette P, Bardin T, Allanore Y, Liot\u00e9 F, Dougados M, Dieud\u00e9 P (2013) Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. Arthritis Res Ther 15:R123","journal-title":"Arthritis Res Ther"},{"key":"4272_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14656566.2017.1351945","volume":"18","author":"T Pascart","year":"2017","unstructured":"Pascart T, Richette P (2017) Current and future therapies for gout. Expert Opin Pharmacother 18:1201\u20131211","journal-title":"Expert Opin Pharmacother"},{"key":"4272_CR10","first-page":"CD009993","volume":"9","author":"F Sivera","year":"2014","unstructured":"Sivera F, Wechalekar MD, Andr\u00e9s M, Buchbinder R, Carmona L (2014) Interleukin-1 inhibitors for acute gout. Cochrane Database Syst Rev 9:CD009993","journal-title":"Cochrane Database Syst Rev"},{"key":"4272_CR11","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","volume":"71","author":"N Schlesinger","year":"2012","unstructured":"Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK (2012) Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 71:1839\u20131848","journal-title":"Ann Rheum Dis"},{"key":"4272_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jbspin.2011.12.017","volume":"79","author":"M Couderc","year":"2012","unstructured":"Couderc M, Mathieu S, Glace B, Soubrier M (2012) Efficacy of anakinra in articular chondrocalcinosis: report of three cases. Joint Bone Spine 79:330\u2013331","journal-title":"Joint Bone Spine"},{"key":"4272_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jbspin.2012.01.010","volume":"79","author":"A Molt\u00f3","year":"2012","unstructured":"Molt\u00f3 A, Ea H-K, Richette P, Bardin T, Liot\u00e9 F (2012) Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Joint Bone Spine 79:621\u2013623","journal-title":"Joint Bone Spine"},{"key":"4272_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/art.23119","volume":"58","author":"D McGonagle","year":"2008","unstructured":"McGonagle D, Tan AL, Madden J, Emery P, McDermott MF (2008) Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum 58:631\u2013633","journal-title":"Arthritis Rheum"},{"key":"4272_CR15","doi-asserted-by":"publisher","first-page":"792173","DOI":"10.1155\/2015\/792173","volume":"2015","author":"A Aouba","year":"2015","unstructured":"Aouba A, Deshayes S, Frenzel L, Decottignies A, Pressiat C, Bienvenu B et al (2015) Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature. Mediat Inflamm 2015:792173","journal-title":"Mediat Inflamm"},{"key":"4272_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RHU.0b013e31826149a2","volume":"18","author":"AP Diamantopoulos","year":"2012","unstructured":"Diamantopoulos AP, Brodin C, Hetland H, Haugeberg G (2012) Interleukin 1\u03b2 blockade improves signs and symptoms of chronic calcium pyrophosphate crystal arthritis resistant to treatment. J Clin Rheumatol 18:310\u2013311","journal-title":"J Clin Rheumatol"},{"key":"4272_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jbspin.2012.07.018","volume":"80","author":"S Ottaviani","year":"2013","unstructured":"Ottaviani S, Brunier L, Sibilia J, Maurier F, Ardizzone M, Wendling D, Gill G, Palazzo E, Meyer O, Dieud\u00e9 P (2013) Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature. Joint Bone Spine 80:178\u2013182","journal-title":"Joint Bone Spine"},{"key":"4272_CR18","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9:R28","journal-title":"Arthritis Res Ther"},{"key":"4272_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","volume":"36","author":"O Gross","year":"2012","unstructured":"Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G et al (2012) Inflammasome activators induce interleukin-1\u03b1 secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36:388\u2013400","journal-title":"Immunity"},{"key":"4272_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.semarthrit.2010.03.001","volume":"40","author":"K Chen","year":"2010","unstructured":"Chen K, Fields T, Mancuso CA, Bass AR, Vasanth L (2010) Anakinra\u2019s efficacy is variable in refractory gout: report of ten cases. Semin Arthritis Rheum 40:210\u2013214","journal-title":"Semin Arthritis Rheum"},{"key":"4272_CR21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/acr.21989","volume":"65","author":"P Ghosh","year":"2013","unstructured":"Ghosh P, Cho M, Rawat G, Simkin PA, Gardner GC (2013) Treatment of acute gouty arthritis in complex hospitalized patients with anakinra. Arthritis Care Res 65:1381\u20131384","journal-title":"Arthritis Care Res"},{"key":"4272_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1136\/ard.2009.108936","volume":"68","author":"R Terkeltaub","year":"2009","unstructured":"Terkeltaub R, Sundy JS, Schumacher HR, Murphy F, Bookbinder S, Biedermann S, Wu R, Mellis S, Radin A (2009) The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis 68:1613\u20131617","journal-title":"Ann Rheum Dis"},{"key":"4272_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jbspin.2012.09.002","volume":"80","author":"F Verhoeven","year":"2013","unstructured":"Verhoeven F, Prati C, Godfrin-Valnet M, Guillot X, Wendling D (2013) IL1 blockade in crystal-induced arthritis: impact of disease duration and the inflammatory syndrome. Comments on the article by Couderc M. et al. \u201cEfficacy of anakinra in articular chondrocalcinosis\u201d. Joint Bone Spine 80:115\u2013116","journal-title":"Joint Bone Spine"},{"key":"4272_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1681\/ASN.2010070760","volume":"22","author":"AM Hung","year":"2011","unstructured":"Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA (2011) IL-1\u03b2 receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol 22:437\u2013442","journal-title":"J Am Soc Nephrol"},{"key":"4272_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semarthrit.2015.02.006","volume":"45","author":"JT Thueringer","year":"2015","unstructured":"Thueringer JT, Doll NK, Gertner E (2015) Anakinra for the treatment of acute severe gout in critically ill patients. Semin Arthritis Rheum 45:81\u201385","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4272-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4272-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T09:01:08Z","timestamp":1567069268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4272-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4272-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"17 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board (No. 12-011) of Paris North Hospitals approved this study. Written informed consent was obtained from all participants in agreement with French bioethics laws.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}